Literature DB >> 7035621

Distribution of measles antigen and immunoglobulin-containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis.

M M Esiri, D R Oppenheimer, B Brownell, M Haire.   

Abstract

The immunoperoxidase technique has been used to study the distribution of measles virus antigen and immunoglobulin (Ig)-containing cells within the CNS, in 5 cases of subacute sclerosing panencephalitis (SSPE) and 1 case of atypical measles encephalitis. Measles virus antigen was demonstrated within the brain in all cases, and in the spinal cord in 1 case of SSPE. Ig-containing cells were also demonstrated in all cases, the proportions of the different light and heavy chain types varying somewhat from case to case. In SSPE IgG constituted the major and IgA the principal minor heavy chain demonstrated. In all cases of SSPE there was significant excess of light-chain-containing over heavy-chain-containing cells. In the case of atypical measles encephalitis there was a paucity of Ig-containing cells and a relatively high proportion (39%) of these contained IgM. The case of atypical measles encephalitis differed from those of SSPE also in the presence of multinucleate giant cells, some of which contained measles virus antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035621     DOI: 10.1016/0022-510x(82)90078-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Experimental measles encephalitis in Lewis rats: dissemination of infected neuronal cell subtypes.

Authors:  Ulrike Jehmlich; Jennifer Ritzer; Jens Grosche; Wolfgang Härtig; Uwe G Liebert
Journal:  J Neurovirol       Date:  2013-08-31       Impact factor: 2.643

2.  hsp72, a host determinant of measles virus neurovirulence.

Authors:  Thomas Carsillo; Zachary Traylor; Changsun Choi; Stefan Niewiesk; Michael Oglesbee
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

Review 3.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

4.  Productive measles virus brain infection and apoptosis in CD46 transgenic mice.

Authors:  A Evlashev; E Moyse; H Valentin; O Azocar; M C Trescol-Biémont; J C Marie; C Rabourdin-Combe; B Horvat
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Measles virus infection and replication in undifferentiated and differentiated human neuronal cells in culture.

Authors:  S McQuaid; S Campbell; I J Wallace; J Kirk; S L Cosby
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 6.  Viral diseases of the central nervous system.

Authors:  Phillip A Swanson; Dorian B McGavern
Journal:  Curr Opin Virol       Date:  2015-02-12       Impact factor: 7.090

Review 7.  Neuroinflammation During RNA Viral Infections.

Authors:  Robyn S Klein; Charise Garber; Kristen E Funk; Hamid Salimi; Allison Soung; Marlene Kanmogne; Sindhu Manivasagam; Shannon Agner; Matthew Cain
Journal:  Annu Rev Immunol       Date:  2019-04-26       Impact factor: 28.527

8.  Widespread, restricted low-level measles virus infection of brain in a case of subacute sclerosing panencephalitis.

Authors:  S H Isaacson; D M Asher; M S Godec; C J Gibbs; D C Gajdusek
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

9.  Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells.

Authors:  J Schneider-Schaulies; J J Schnorr; J Schlender; L M Dunster; S Schneider-Schaulies; V ter Meulen
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Major histocompatibility complex haplotype determines hsp70-dependent protection against measles virus neurovirulence.

Authors:  Thomas Carsillo; Mary Carsillo; Zachary Traylor; Päivi Rajala-Schultz; Phillip Popovich; Stefan Niewiesk; Michael Oglesbee
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.